Merck
Most Read
U.S. reports 180 cases of unexplained hepatitis in children, as researchers investigate potential causes
Up and down the ladder: The latest comings and goings
‘No real clear path’: Insurance coverage for cutting-edge diagnostics remains a major challenge for personalized medicine
Pharmalittle: Cancer coalition aims to boost access to meds in poor countries; Moderna’s vaccine patent defense poses shield for others
To improve safety, hospitals should make ‘radical transparency’ real — and accessible
Hopelessness around youth mental health is creating a ‘nihilistic contagion’
